Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Bicalutamide
Drug ID BADD_D00271
Description Bicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It is comprised of a racemic mixture that is a 50:50 composition of the (R)-bicalutamide and (S)-bicalutamide enantionmers. Bicalutamide binds to the androgen receptor.
Indications and Usage For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer.
Marketing Status Prescription; Discontinued
ATC Code L02BB03
DrugBank ID DB01128
KEGG ID D00961
MeSH ID C053541
PubChem ID 2375
TTD Drug ID D0V9BD
NDC Product Code 60429-177; 70518-2993; 51846-1028; 16714-816; 62559-680; 0904-6019; 16729-023; 43265-0705; 15308-0360; 54893-0001; 49711-1504; 65841-613; 43265-7195; 49711-1509; 71205-577; 68382-224; 47335-485; 63629-8308; 63759-0004; 62559-890; 53104-7664; 46014-1111; 58623-0068
Synonyms bicalutamide | 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide | Casodex | Cosudex | ICI-176334 | ICI 176334
Chemical Information
Molecular Formula C18H14F4N2O4S
CAS Registry Number 90357-06-5
SMILES CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Diarrhoea07.02.01.001--
Dilatation ventricular02.04.02.0260.006444%Not Available
Disorientation19.13.01.002; 17.02.05.0150.016111%Not Available
Disseminated intravascular coagulation01.01.02.002; 24.01.01.0100.005043%
Diverticulitis11.01.07.003; 07.10.02.0010.016111%Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Drug eruption10.01.01.005; 23.03.05.001; 08.01.06.0150.012889%Not Available
Dry mouth07.06.01.002--
Dry skin23.03.03.001--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyskinesia17.01.02.0060.006444%
Dyspepsia07.01.02.001--
Dysphagia07.01.06.003--
Dysphonia22.02.05.005; 19.19.03.002; 17.02.08.004--
Dyspnoea22.02.01.004; 02.01.03.0020.099889%
Dyspnoea at rest22.02.01.025; 02.01.03.0070.009667%Not Available
Dyspnoea exertional22.02.01.005; 02.01.03.0030.019333%Not Available
Dysuria20.02.02.0020.048333%
Ecchymosis24.07.06.002; 23.06.01.001; 01.01.03.0010.006444%Not Available
Eczema23.03.04.0060.006444%
Electrocardiogram QT prolonged13.14.05.0040.029000%
Electrocardiogram ST segment elevation13.14.05.0250.006444%Not Available
Emphysema22.01.02.0020.001681%Not Available
Encephalopathy17.13.02.0010.006444%
Eosinophilia01.02.04.001--
Epistaxis22.04.03.001; 24.07.01.005--
Erythema23.03.06.001--Not Available
Erythema multiforme23.03.01.003; 10.01.03.0150.012889%
Essential tremor17.01.06.0040.006444%Not Available
Eyelid oedema10.01.05.001; 06.04.04.004; 23.04.01.0030.006444%Not Available
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 17 Pages